BU
SYNH

BBVA USA’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

BBVA USA’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.42M Sell
16,219
-417
-3% -$37.7K 0.08% 220
2021
Q2 		$1.49M Buy
+16,636
New +$1.41M 0.08% 223

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BBVA USA's SYNH Position: Q3 2021 in Review

BBVA USA reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 2.5% in Q3 2021, selling an estimated $37.7K and leaving 16,219 shares worth $1.42M. The position accounts for 0.08% of the portfolio, ranked #220.

BBVA USA first reported a position in SYNH in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.49M in Q2 2021. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

  • BBVA USA held 16,219 shares of Syneos Health, Inc. Class A Common Stock worth $1.42M as of Q3 2021.
  • BBVA USA sold 417 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $37.7K.
  • Syneos Health, Inc. Class A Common Stock made up 0.08% of BBVA USA's portfolio in Q3 2021, its #220 holding.
  • BBVA USA first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Syneos Health, Inc. Class A Common Stock position peaked at $1.49M in Q2 2021.
  • 355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.